positioning of biologics and new therapeutics for crohn's disease
Published 6 years ago • 3.8K plays • Length 12:58Download video MP4
Download video MP3
Similar videos
-
12:13
positioning of biologics and new therapeutics for ulcerative colitis
-
21:02
should we change how we position biologics for use in crohn’s disease?
-
21:04
positioning of biologics in the clinic
-
23:44
mechanisms of disease: biologic pipeline for ibd
-
21:14
when and how to use immunomodulators and biologics in ibd
-
8:05
reversing crohn’s disease naturally india: crohn’s recovery story
-
42:52
10 keys to conquer crohn's & colitis
-
7:25
understanding cidp (chronic inflammatory demyelinating polyradiculoneuropathy)
-
20:08
biologics and mucosal healing in crohn’s disease: available evidence
-
15:56
therapeutic approaches to ibd in 2020 and beyond
-
49:17
the evolving therapeutic paradigm in ibd: optimal positioning of new and emerging agents
-
21:36
crohn's disease: recent and emerging therapies
-
23:55
new biologic therapies that target the il-12/23 pathway
-
16:13
positioning our recent and future advances in therapies for crohn's disease
-
21:36
how will future therapeutic pathways change for ulcerative colitis and crohn's disease?
-
17:44
implementing treatment pathways for the management of ulcerative colitis and crohn's disease
-
17:51
personalizing care in crohn’s disease management
-
12:32
use of anti-tnf therapies for crohn's disease
-
1:22
treating ibd: biologics
-
18:38
positioning anti-il-12 and anti-il-23 inhibitors
-
33:18
state of the art: positioning therapies in ibd
-
15:15
first line therapies for ulcerative colitis and crohn's disease